Dr. Jeffrey Cirillo is leading a national team that hopes to repurpose an existing tuberculosis vaccine to fight the coronavirus. About 700 participants are needed in Texas for the clinical trial.
A Texas A&M researcher says results from clinical trials indicate that they could be an effective way to treat coronavirus patients who develop complications.
A combination of fear, service to others and technology have contributed to reduced hospital visits for cases unrelated to COVID-19. But a Texas A&M expert cautions against avoiding medical care altogether.
Texas A&M researchers, alongside the Houston Methodist Research Institute and Houston Methodist Hospital system, assessed how front-line health care workers have been affected by the pandemic.
While the pandemic and oil glut create a double dose of devastation, three Texas A&M scholars tell Chancellor John Sharp that they see new economic opportunities rising from the rubble.
